Fund Holdings — Altium Capital Management LLC

Total Portfolio Value:
$223.92M
Total Bought:
$113.49M
Total Sold:
$38.90M
Net Transaction:
+$74.59M
Securities
▲▼
SharesValue
Q4 2023
▲▼
Q1 2024
▲▼
Change
▲▼
Q4 2023
▲▼
Q1 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Vera Therapeutics, Inc.CL A(VERA)615,000710,000+95,000$9.46M$30.62M13.67%+$21.16M
Xenon Pharmaceuticals Inc.(XENE)290,535348,000+57,465$13.38M$14.98M6.69%+$1.60M
Axsome Therapeutics, Inc.(AXSM)138,000138,0000$10.98M$11.01M4.92%+$29.0K
Adma Biologics Inc1,095,0001,540,000+445,000$4.95M$10.16M4.54%+$5.21M
Alimera Sciences Inc2,660,0002,550,000-110,000$11.49M$9.95M4.44%-$1.55M
Avadel Pharmaceuticals PlcADR0553,057+553,057$0$9.34M4.17%+$9.34M
Xtant Medical Holdings, Inc.(XTNT)8,027,5937,647,873-379,720$9.07M$8.95M4.00%-$123.2K
Catalyst Pharmaceuticals Inc385,000500,000+115,000$6.47M$7.97M3.56%+$1.50M
Intra-Cellular Therapies Inc71,000113,000+42,000$5.09M$7.82M3.49%+$2.73M
Biohaven Ltd.(BHVN)0140,000+140,000$0$7.66M3.42%+$7.66M
Viking Therapeutics, Inc.(VKTX)085,000+85,000$0$6.97M3.11%+$6.97M
Olema Pharmaceuticals, Inc.(OLMA)413,607605,000+191,393$5.80M$6.85M3.06%+$1.05M
Savara Inc.(SVRA)1,333,0001,335,000+2,000$6.27M$6.65M2.97%+$383.2K
Soleno Therapeutics Inc104,909152,909+48,000$4.22M$6.54M2.92%+$2.32M
Cybin D/B/A Helus Pharma(HELP)013,953,488+13,953,488$0$5.77M2.58%+$5.77M
ORIC Pharmaceuticals, Inc.(ORIC)676,000405,000-271,000$6.22M$5.57M2.49%-$650.5K
Larimar Therapeutics, Inc.(LRMR)0695,000+695,000$0$5.28M2.36%+$5.28M
Mirum Pharmaceuticals, Inc.(MIRM)0208,000+208,000$0$5.22M2.33%+$5.22M
Neurogene Inc.(NGNE)66,981100,000+33,019$1.30M$5.09M2.27%+$3.79M
Praxis Precision Medicines, Inc.(PRAX)078,100+78,100$0$4.77M2.13%+$4.77M
Achieve Life Sciences Inc0835,470+835,470$0$3.80M1.70%+$3.80M
Ascendis Pharma A/SADR(ASND)25,00025,0000$3.15M$3.78M1.69%+$630.5K
Longboard Pharmaceuticals In0170,000+170,000$0$3.67M1.64%+$3.67M
Insmed Incorporated(INSM)120,000120,0000$3.72M$3.26M1.45%-$463.2K
The RealReal, Inc.(REAL)0800,000+800,000$0$3.13M1.40%+$3.13M
Alpine Immune Sciences Inc78,72377,848-875$1.50M$3.09M1.38%+$1.59M
Boundless Bio, Inc.(BOLD)0200,000+200,000$0$2.85M1.27%+$2.85M
Aquestive Therapeutics Inc0665,000+665,000$0$2.83M1.27%+$2.83M
Rhythm Pharmaceuticals, Inc.(RYTM)6,48557,271+50,786$298.1K$2.48M1.11%+$2.18M
Milestone Pharmaceuticals Inc.(MIST)01,212,882+1,212,882$0$2.17M0.97%+$2.17M
Astria Therapeutics Inc730,000142,532-587,468$5.61M$2.01M0.90%-$3.60M
Zevra Therapeutics, Inc.(ZVRA)0341,461+341,461$0$1.98M0.88%+$1.98M
Marinus Pharmaceuticals Inc200,000176,840-23,160$2.17M$1.60M0.71%-$575.4K
BioVie Inc.CL A(BIVI)03,012,608+3,012,608$0$1.59M0.71%+$1.59M
Tourmaline Bio Inc065,442+65,442$0$1.50M0.67%+$1.50M
Veru Inc.(VERU)2,000,0002,111,731+111,731$1.44M$1.48M0.66%+$38.4K
Karyopharm Therapeutics Inc.(KPTI)740,000740,0000$640.1K$1.12M0.50%+$477.3K
Fat Brands IncW EXP 07 16 202200,000200,0000$680.0K$974.0K0.43%+$294.0K
Spruce Biosciences Inc01,150,000+1,150,000$0$903.8K0.40%+$903.8K
Perspective Therapeutics, Inc.(CATX)0535,657+535,657$0$637.4K0.28%+$637.4K
Evoke Pharma Inc0724,942+724,942$0$442.2K0.20%+$442.2K
Perfect Moment Ltd. Common Stock(PMNT)092,208+92,208$0$330.1K0.15%+$330.1K
Rocket Pharmaceuticals, Inc.W EXP 09 02 202(RCKT)0731,561+731,561$0$218.9K0.10%+$218.9K
Nexgel IncW EXP 12 01 202225,000225,0000$110.3K$162.0K0.07%+$51.8K
Mobilicom LimitedADS(MOB)0135,292+135,292$0$161.0K0.07%+$161.0K
Gri Bio Inc0187,981+187,981$0$142.9K0.06%+$142.9K
Wearable Devices LtdW EXP 09 14 2021,411,6001,411,6000$98.8K$109.5K0.05%+$10.7K
Azitra Inc0493,153+493,153$0$101.3K0.05%+$101.3K
Nocturne Acquisition CorpRIGHT 12 26 2025500,000500,0000$82.4K$82.0K0.04%-$400
Quoin Pharmaceuticals LtdADS066,240+66,240$0$62.9K0.03%+$62.9K
Mobix Labs, Inc.W EXP 99 99 999(MOBX)150,000150,0000$10.5K$31.5K0.01%+$21.0K
Digital Health Acquisition CW EXP 99 99 999150,000150,0000$3.9K$19.2K0.01%+$15.3K
Onfolio Holdings, Inc.W EXP 01 02 202(ONFO)200,000200,0000$16.0K$8.1K0.00%-$7.9K
Nls Pharmaceutics LtdW EXP 02 02 202200,000200,0000$11.2K$6.9K0.00%-$4.3K
CDT Equity Inc.W EXP 09 22 202(CDT)100,000100,0000$6.9K$6.0K0.00%-$930
Cingulate Inc.W EXP 12 10 202(CING)270,000270,0000$8.1K$5.7K0.00%-$2.4K
Bitcoin Depot IncW EXP 06 30 20250,00050,0000$7.3K$4.7K0.00%-$2.5K
Nexalin Technology IncW EXP 99 99 999105,000105,0000$924$4.4K0.00%+$3.5K
Cycurion, Inc.W EXP 99 99 999(CYCU)100,000100,0000$3.2K$4.3K0.00%+$1.1K
Nexera Technologies LtdW EXP 99 99 999(NEXR)68,68168,6810$2.6K$4.0K0.00%+$1.4K
Surrozen, Inc.W EXP 08 01 203(SRZN)82,23382,2330$1.4K$3.4K0.00%+$2.0K
BNB Standard CorporationW EXP 02 11 202(BNC)250,000250,0000$3.0K$3.3K0.00%+$262
Prosomnus IncW EXP 04 20 202150,000150,0000$4.3K$3.0K0.00%-$1.3K
Coliseum Acquisition CorpW EXP 08 22 20228,33328,3330$1.1K$1.9K0.00%+$737
Selina Hospitality PlcW EXP 10 27 202101,439101,4390$426$7100.00%+$284
Tc Biopharm Holdings PlcW EXP 02 10 20218,82318,8230$612$3760.00%-$236
Bruush Oral Care IncW EXP 08 03 20214,42314,4230$98$1100.00%+$12
Relativity Acquisition CorpW EXP 12 15 202100,000100,0000$0$0—$0
Advisorshares TrPURE US CANNABIS
PURE US CANN ETF
80,0000-80,000$560.8K$0—-$560.8K
Amylyx Pharmaceuticals, Inc.(AMLX)119,5260-119,526$1.76M$0—-$1.76M
Arvinas, Inc.(ARVN)31,2100-31,210$1.28M$0—-$1.28M
Filana Therapeutics, Inc.(FLNA)13,0000-13,000$292.6K$0—-$292.6K
Crinetics Pharmaceuticals In65,0000-65,000$2.31M$0—-$2.31M
Cyclacel Pharmaceuticals Inc37,9820-37,982$101.4K$0—-$101.4K
Cymabay Therapeutics Inc111,0000-111,000$2.62M$0—-$2.62M
Cytokinetics, Incorporated(CYTK)20,0000-20,000$1.67M$0—-$1.67M
DiaMedica Therapeutics Inc.(DMAC)287,6980-287,698$817.1K$0—-$817.1K
DoubleDown Interactive Co., Ltd.ADS(DDI)60,8760-60,876$447.4K$0—-$447.4K
Ea Series TrustALPHA ARCH 1 3
ALPHA ARCH 1-3
92,7000-92,700$9.75M$0—-$9.75M
enVVeno Medical Corporation(NVNO)344,4710-344,471$1.77M$0—-$1.77M
Fortress Biotech, Inc.(FBIO)405,1220-405,122$1.22M$0—-$1.22M
Immunovant, Inc.(IMVT)80,0000-80,000$3.37M$0—-$3.37M
Novabay Pharmaceuticals Inc67,4570-67,457$13.8K$0—-$13.8K
Pepperlime Health Acqustn CoW EXP 10 01 202367,5000-367,500$11.1K$0—-$11.1K
Sadot Group Inc168,2350-168,235$67.4K$0—-$67.4K
Sagimet Biosciences Inc.COM SER A(SGMT)483,1810-483,181$2.53M$0—-$2.53M
Tg Venture Acquisition CorpW EXP 08 15 202200,0000-200,000$3.0K$0—-$3.0K
Tonix Pharmaceuticals Hldg C540,0250-540,025$217.6K$0—-$217.6K
Page 1 of 1
Altium Capital Management LLC — 13F Holdings — Q1 2024 | TickerTrail